Agios Pharmaceuticals Aktie
33,60
EUR
-0,60
EUR
-1,75
%
34,18
USD
-1,14
USD
-3,23
%
Agios Pharmaceuticals Aktie Analyse
| 15.02.18 | Agios Pharmaceuticals Buy | Needham & Company, LLC | |
| 15.09.17 | Agios Pharmaceuticals Outperform | RBC Capital Markets | |
| 10.08.17 | Agios Pharmaceuticals Buy | Needham & Company, LLC | |
| 24.10.16 | Agios Pharmaceuticals Buy | Needham & Company, LLC | |
| 18.05.16 | Agios Pharmaceuticals Buy | SunTrust Robinson Humphrey, Inc. | |
| 30.03.16 | Agios Pharmaceuticals Buy | SunTrust Robinson Humphrey, Inc. | |
| 09.11.15 | Agios Pharmaceuticals Neutral | ROTH Capital Partners, LLC | |
| 22.07.15 | Agios Pharmaceuticals Outperform | Northland Capital | |
|
Werbung
|
|||
| 15.06.15 | Agios Pharmaceuticals Hold | Canaccord Adams | |
| 21.04.15 | Agios Pharmaceuticals Perform | Oppenheimer & Co. Inc. | |
| 18.02.15 | Agios Pharmaceuticals Buy | MLV Capital | |
| 05.01.15 | Agios Pharmaceuticals Neutral | ROTH Capital Partners, LLC | |
| 04.12.14 | Agios Pharmaceuticals Buy | MLV Capital | |
| 19.11.14 | Agios Pharmaceuticals Buy | Canaccord Adams | |
| 12.11.14 | Agios Pharmaceuticals Buy | Canaccord Adams | |